The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Daniel William F since 2015.
This trader's CIK number is 1529409.
At the time of last reporting, Daniel William F was the Director of Horizon Therapeutics Public Ltd Co. (stock ticker symbol HZNP).
Also see all insider trading activities at Horizon Therapeutics Public Ltd Co.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | HZNP | 0 | $0 | 0 | $0 | 3,913 | $0 |
| 2022 | HZNP | 0 | $0 | 0 | $0 | 4,223 | $0 |
| 2021 | HZNP | 0 | $0 | 20,000 | $1,735,700 | 20,000 | $254,000 |
| 2020 | HZNP | 0 | $0 | 0 | $0 | 15,390 | $0 |
| 2019 | HZNP | 0 | $0 | 0 | $0 | 15,320 | $0 |
| 2018 | HZNP | 0 | $0 | 0 | $0 | 14,054 | $0 |
| 2017 | HZNP | 0 | $0 | 0 | $0 | 21,827 | $0 |
| 2016 | HZNP | 0 | $0 | 0 | $0 | 13,132 | $0 |
| 2015 | HZNP | 0 | $0 | 0 | $0 | 7,874 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-04-28 | HZNP | Option Ex | 3,913 | .00 | 0 |
| 2022-04-29 | HZNP | Option Ex | 4,223 | .00 | 0 |
| 2021-05-10 | HZNP | Option Ex | 20,000 | 12.70 | 254,000 |
| 2021-05-10 | HZNP | Sale | 20,000 | 86.78 | 1,735,700 |
| 2020-05-02 | HZNP | Option Ex | 15,390 | .00 | 0 |
| 2019-05-03 | HZNP | Option Ex | 15,320 | .00 | 0 |
| 2018-05-03 | HZNP | Option Ex | 14,054 | .00 | 0 |
| 2017-09-19 | HZNP | Option Ex | 7,874 | .00 | 0 |
| 2017-05-03 | HZNP | Option Ex | 13,953 | .00 | 0 |
| 2016-09-19 | HZNP | Option Ex | 7,874 | .00 | 0 |
| 2016-05-06 | HZNP | Option Ex | 5,258 | .00 | 0 |
| 2015-09-19 | HZNP | Option Ex | 7,874 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Daniel William F (Director of Horizon Therapeutics Public Ltd Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.